Dr. Lado allegedly violated the False Claims Act by purchasing unapproved Botox from outside the U.S. in order to cut costs, using it to treat Medicare beneficiaries, and then billing Medicare for it.
The use of the unapproved Botox began in 2018, according to the statement.
The department said government officials intercepted several packages of the unapproved drugs and informed Elite Medical. The practice allegedly still used the drugs following the warning.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.